MapLight Therapeutics (MPLT) Change in Cash (2024 - 2025)

MapLight Therapeutics' (MPLT) quarterly Change in Cash came in at -$17.4 million in Q4 2025, down 259.63% year-on-year from $10.9 million in Q4 2024, and down 259.63% quarter-over-quarter from $10.9 million in Q4 2024.

MapLight Therapeutics (MPLT) Change in Cash (2024 - 2025) Analysis & Trends

MapLight Therapeutics has disclosed Change in Cash across 2 years of filings, most recently posting -$17.4 million for Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 2.44 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 623.00 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -2.44 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 417.10 Mn
9 Abivax 91.96 Bn 91.96 Bn - -45.97 Mn
10 MapLight Therapeutics 248.88 Mn 248.88 Mn - -17.42 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -17.42 Mn
Dec 31, 2024 10.91 Mn